Analysts await Arotech Corporation (NASDAQ:ARTX) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $0.04 EPS, up 50% or $0.02 from last year’s $0.02 per share.

At the moment 1 analyst is watching Arotech Corporation (NASDAQ:ARTX), 0 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Jun-16, 1 analyst has a mean sales target of 27.38 million. For the quarter ending Sep-16, 1 analyst has a mean sales target of 27.73 million whilst for the year ending Dec-16, 1 analyst has a mean target of 109.57 million.

In terms of earnings per share, 1 analyst has a 0.02 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 1 analyst has a 0.03 EPS mean target and for the quarter ending Sep-16 there are 1 estimate of 0.03 EPS.

The biggest institutional shareholders in Arotech Corporation include Vanguard Group Inc which owns 683 K million shares in the company valued at $1.39 million. Dimensional Fund Advisors, Inc. is the second biggest holder with 461 K million shares currently valued at 940.00 K million whilst Bridgeway Capital Management, Inc has 381 K million shares valued at 778.00 K million.

Total shares held by institutions as of the most recent company filings are 3,092,769 with a reported 54,542 bought and 181,343 sold. These holdings make up 12.52% of the company’s outstanding shares.

Currently insiders hold 3,307,987 shares in the business which makes up 13.39% of shares. The biggest holder currently is Mr. Robert S. Ehrlich who owns 1,143,178 shares (4.32% of those outstanding), whilst Mr. Steven Esses holds 1,099,513 (4.16% of shares outstanding) and Thomas J. Paup holds 315,026 (1.19% of shares outstanding).

The stock decreased 3.54% or $0.13 during the last trading session.